• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号

GLP-1(7-37)

CAS No. 106612-94-6

GLP-1(7-37) ( —— )

产品货号. M30005 CAS No. 106612-94-6

GLP-1 (7-37) is a truncated, bioactive form of GLP-1 that is the product of proglucagon processing in intestinal endocrine L cells.

纯度: >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
500MG 获取报价 有现货
1G 获取报价 有现货

生物学信息

  • 产品名称
    GLP-1(7-37)
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    GLP-1 (7-37) is a truncated, bioactive form of GLP-1 that is the product of proglucagon processing in intestinal endocrine L cells.
  • 产品描述
    GLP-1 (7-37) is a truncated, bioactive form of GLP-1 that is the product of proglucagon processing in intestinal endocrine L cells.(In Vivo):GLP-1(7-37) (0.5, 5 or 50 pmol/min/kg) infused during the second hour of a 2-hour 11-mM hyperglycemic clamp produces a dose-related enhancement of the glucose-stimulated increase in plasma insulin concentration and an increased rate of glucose infusion in rats. Infusion of GLP-1(7-37) (5 pmol/min/kg) from 1 hour through 7 hours produces a sustained increase in plasma insulin concentration relative to levels in rats infused with vehicle in rats with maintained glucose concentration at 11 mM.
  • 体外实验
    ——
  • 体内实验
    GLP-1(7-37) (0.5, 5 or 50 pmol/min/kg) infused during the second hour of a 2-hour 11-mM hyperglycemic clamp produces a dose-related enhancement of the glucose-stimulated increase in plasma insulin concentration and an increased rate of glucose infusion in rats.Infusion of GLP-1(7-37) (5 pmol/min/kg) from 1 hour through 7 hours produces a sustained increase in plasma insulin concentration relative to levels in rats infused with vehicle in rats with maintained glucose concentration at 11 mM. Animal Model:Male Sprague-Dawley rats weighing 300 to 350 g with maintained plasma glucose concentration at 11 mM.Dosage:0.5, 5 or 50 pmol/min/kg.Administration:IV during the second hour of a 2-hour 11-mmol/L hyperglycemic clamp.Result:Produced a dose-related enhancement of the glucose-stimulated increase in plasma insulin concentration and an increased rate of glucose infusion.Animal Model:Male Sprague-Dawley rats weighing 300 to 350 g with glucose IV at a variable.rate for 7 hours to maintain plasma glucose concentration at 11 mM.Dosage:5 pmol/min/kg.Administration:IV from 1 hour through 7 hours.Result:Produced a sustained increase in plasma insulin concentration relative to levels in rats infused with vehicle.
  • 同义词
    ——
  • 通路
    GPCR/G Protein
  • 靶点
    Glucagon Receptor
  • 受体
    ——
  • 研究领域
    ——
  • 适应症
    ——

化学信息

  • CAS Number
    106612-94-6
  • 分子量
    3355.67
  • 分子式
    C151H228N40O47
  • 纯度
    >98% (HPLC)
  • 溶解度
    H2O : 30 mg/mL (8.94 mM; Need ultrasonic and warming)
  • SMILES
    ——
  • 化学全称
    Sequence:His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Gly-Arg-Gly

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

Sarrauste de Menthiere, C. et al. Structural requirements of the N-terminal region of GLP-1-[7-37]-NH2 for receptor interaction and cAMP production. European journal of medicinal chemistry 39, 473-480, doi:10.1016/j.ejmech.2004.02.002 (2004).
产品手册
关联产品
  • Methylprodnisolone S...

    Methylprednisolone succinate (Methylprednisolone hydrogen succinate) sodium 是一种糖皮质激素, 半衰期较Prednisolone长,是一种有效的抗炎剂。

  • GLP-1 (9-36) amide

    GLP-1(9-36)amide 是胰高血糖素样肽-1 (7-36) amide 的主要代谢产物。GLP-1(9-36)amide 是一种人胰腺 GLP-1 受体的拮抗剂。

  • Retatrutide

    Retatrutide (LY3437943) 是胰高血糖素受体 (GCGR)、葡萄糖依赖性促胰岛素多肽受体 (GIPR) 和胰高血糖素样肽-1 受体 (GLP-1R) 的三重激动剂肽。Retatrutide 结合人 GCGR、GIPR 和 GLP-1R,EC50 值分别为 5.79、0.0643 和 0.775 nM。Retatrutide 可用于肥胖的研究。